Organizational Impact of Reflex IgM Testing for Enzymatic Creatinine Interference: A Real-World Study
Open Access
- 3 September 2026
- journal article
- research article
- Published by MDPI AG in Laboratories
- Vol. 3 (3) , 20
Abstract
Introduction: Immunoglobulin M (IgM) paraproteins may interfere with enzymatic creatinine assays, potentially affecting renal function assessment. Reflex IgM testing has been proposed to detect such interference, but its impact on laboratory workflow remains insufficiently characterized. Material and Methods: This retrospective observational study combined two complementary datasets: (1) a clinical cohort of patients evaluated for suspected IgM-related interference over a 7-month period, and (2) a two-month and half representative operational analysis assessing testing volume and turnaround time (TAT) in a high-throughput clinical laboratory. An automated LIS rule triggered IgM testing when creatinine was ≥177 μmol/L. Samples with IgM ≥ 2.5 g/L underwent polyethylene glycol (PEG) precipitation to evaluate potential interference. Test volume and TAT were compared between creatinine-only and reflex workflows. Results: During the 2.5-month operational analysis, 102,849 creatinine measurements were performed, of which 7740 (7.5%) triggered reflex IgM testing, generating 11,091 IgM determinations, 56.5% of which were reflex-driven. During the full seven-month clinical observation period, clinically relevant IgM-related interference was confirmed in 8 patients. Reflex workflows were associated with increased TAT compared with creatinine-only testing. Conclusions: Universal reflex IgM testing improves detection of rare analytical interference but generates substantial workload and increases TAT. During the 2.5-month operational analysis period, only 2 of 7740 reflex-triggered samples (0.026%) resulted in confirmed clinically relevant interference. A selective, risk-based strategy may therefore represent a more efficient and sustainable approach to routine laboratory practice.Keywords
This publication has 15 references indexed in Scilit:
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- Artefactually low creatinine by Beckman Coulter enzymatic method due to immunoglobulin M paraprotein interferenceAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2023
- Negative interference from immunoglobulin M paraproteinaemia on the Roche enzymatic creatinine methodAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2022
- Falsely Elevated Serum Creatinine Associated With IgM ParaproteinemiaKidney International Reports, 2020
- A Risk Assessment of the Jaffe vs Enzymatic Method for Creatinine Measurement in an Outpatient PopulationPLOS ONE, 2015
- Rare IgM Interference with Roche/Hitachi Modular Glucose and γ-Glutamyltransferase Methods in Heparin SamplesClinical Chemistry, 2005
- False Increase in Serum C-Reactive Protein Caused by Monoclonal IgM-λ: a Case ReportClinical Chemistry and Laboratory Medicine (CCLM), 2001
- Pseudohypercreatininemia due to Positive Interference in Enzymatic Creatinine Measurements Caused by Monoclonal IgM in Patients with Waldenström’s MacroglobulinemiaNephron, 2000
- Serum Creatinine as an Index of Renal Function: New Insights into Old ConceptsClinical Chemistry, 1992
- Advantages of sequential polyethylene glycol (PEG) precipitations to isolate and analyze circulating immune complexesImmunology Letters, 1984